Robinhood Markets, Inc.’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BDTX
Robinhood Markets, Inc.'s BDTX Position: Q3 2026 in Review
Robinhood Markets, Inc. opened a new position in Black Diamond Therapeutics (BDTX) in Q3 2026: 31 shares worth $59. The stake represents ﹤0.01% of the portfolio and ranks #1205 among its holdings.
111 funds tracked by Wall St. Rank hold BDTX as of Q3 2026.
- Robinhood Markets, Inc. held 31 shares of Black Diamond Therapeutics worth $59 as of Q3 2026.
- Black Diamond Therapeutics was a new Robinhood Markets, Inc. position in Q3 2026.
- Black Diamond Therapeutics made up ﹤0.01% of Robinhood Markets, Inc.'s portfolio in Q3 2026, its #1205 holding.
- 111 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q3 2026.
Based on Robinhood Markets, Inc.'s 13F filing for Q3 2026, filed 18 Nov 2026.